These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6223287)

  • 1. Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    Jensen KM; Madsen PO
    Prostate; 1983; 4(4):407-14. PubMed ID: 6223287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of ciprofloxacin in the dog prostate and various tissues.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amifloxacin distribution in the dog prostate.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Prostate; 1985; 6(2):163-8. PubMed ID: 3975177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic tissue concentrations of rosoxacin.
    Jensen KM; Patel RB; Welling PG; Madsen PO
    Prostate; 1982; 3(5):523-9. PubMed ID: 7145776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO; Izard D; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosoxacin distribution in kidney and prostate: experimental studies in dogs.
    Maigaard S; Frimodt-Möller N; Madsen PO
    Urol Res; 1980; 8(2):113-6. PubMed ID: 7394950
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential usefulness of norfloxacin in the treatment of urinary tract infections.
    Norrby SR
    Eur J Clin Microbiol; 1983 Jun; 2(3):227-9. PubMed ID: 6224677
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of rosoxacin and its N-oxide metabolite in plasma and urine.
    Kullberg MP; Koss R; O'Neil S; Edelson J
    J Chromatogr; 1979 May; 173(1):155-63. PubMed ID: 546869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of quinolones in urinary tract infections and prostatitis.
    Naber KG
    Rev Infect Dis; 1989; 11 Suppl 5():S1321-37. PubMed ID: 2672257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial substances in secretion, interstitial fluid, and tissue of normal and infected canine prostate glands.
    Baumueller A; Madsen PO
    Urol Res; 1982 Feb; 10(1):31-5. PubMed ID: 7200274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of quinolones in treatment of prostatitis and lower urinary tract infections.
    Andriole VT
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):342-50. PubMed ID: 1864295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P; Renaudin H; Quentin C; Bebear C
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of conjugal transfer by new quinolinic compounds.
    Oliva B; Selan L; Ravagnan G; Renzini G
    Chemioterapia; 1985 Jun; 4(3):199-201. PubMed ID: 3161641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Siddiqui Y; Gruninger RP
    Antimicrob Agents Chemother; 1981 Aug; 20(2):265-6. PubMed ID: 6456692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
    Panichi G; Pantosti A; Testore GP
    J Antimicrob Chemother; 1983 Jun; 11(6):589-92. PubMed ID: 6224769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
    Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolones in urology.
    Nielsen KT; Madsen PO
    Urol Res; 1989; 17(2):117-24. PubMed ID: 2660393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.